🧬 NEW: Greater exposure to adverse childhood experiences (#ACEs) was associated with lower mitochondrial DNA copy number in children, and lower mtDNAcn was linked to higher odds of atopic dermatitis ➡️ ow.ly/38Lk50ZbAXQ #Dermatology #AtopicDermatitis #PediatricDermatology #SkinHealth #Psychodermatology #Research

💊 NEW: A recent VHA analysis supports nicotinamide as a cost-effective prevention strategy for high-risk patients 👉 ow.ly/5CE050ZbpgO #Dermatology

🧬GENE EXPRESSION PROFILING IN MELANOMA: The next frontier in skin cancer management may lie in tumor biology—not just staging. Gene Expression Profiling (GEP) is increasingly being used to complement traditional clinicopathologic risk assessment in melanoma and cutaneous squamous cell carcinoma ➡️ ow.ly/6r2F50Z9c1S #PrecisionMedicine #Dermatology #Melanoma #CutaneousOncology #SkinCancer #MohsSurgery #CancerGenomics #MedicalInnovation #DermOncology

🧬 NEW IN THE MAY/JUNE ISSUE🧬 Precision medicine may be changing the future of giant congenital melanocytic nevi (GCMN) ➡️ ow.ly/ASXR50Z8mH7 #Dermatology #PrecisionMedicine #Melanoma #SkinCancer #PediatricDermatology #RareDisease #TranslationalResearch #MedicalInnovation

🩺 ✅ ICYMI: A CLINIC-READY PRIMER FOR PEDIATRIC HS TREATMENT -- Get the latest with this practical, clinic-ready approach to pediatric HS, focusing on diagnostic recognition, comorbidity screening, severity-based management, and procedural and psychosocial considerations unique to children and adolescents. Read it here ➡️ ow.ly/G2IZ50Z6awp #PediatricHS #HidradenitisSuppurativa #PediatricDermatology #Dermatology #Skin #PediatricCare

🔎📊 ANALYZING RECENT DEURUXOLITINIB DATA: Arash Mostaghimi, MD, MPH, FAAD, Vice Chair of Clinical Trials and Innovation for the Brigham & Women's Hospital Department of Dermatology, discusses reently released data on deuruxolitinib for the treatment of alopecia areata ➡️ ow.ly/Arsb50Z6aom #AlopeciaAreata #Deuruxolitinib #DermatologyResearch #ClinicalTrials #BrighamWomensHospital #SkinHealth #Dermatology

💪🩺 BE BOLD:New data from the Phase 3 BE BOLD study show that #bimekizumab (Bimzelx; UCB achieved superior joint responses compared with #risankizumab in adults with active psoriatic arthritis (PsA). Read more ➡️ ow.ly/YMuN50Z8fzs #Bimzelx #PsoriaticArthritis #Rheumatology

🌈 🩺 🎤A MATTER OF TRUST: Dermatologist Steve Daveluy, MD, gives a talk reviewing best practices for optimizing comfort and trust between providers and sexual and gender minority (SGM) patients at the From Evidence to Equity (FETE): Dermatologic Care for Sexual and Gender Minorities conference in Washington, D.C.

🎤👨‍⚕️👩‍⚕️ON SCENE: Practical Dermatology attended the From Evidence to Equity: Dermatologic Care for Sexual and Gender Minorities (FETE) symposium, where the focus was on the unique considerations for patients who are members of sexual and gender minorities. Pictured is dermatologist Dr. John Trinidad addressing attendees on updated terminology for use in clinical practices. #Dermatology #SkinHealth #LGBTQHealth #GenderDiversity #InclusiveCare #MedicalEducation #HealthcareEquity

👴🩺TREATING HAIR LOSS AND THINNING HAIR IN MEN OVER 50: In this edition of Practical Dermatology's Skin Minutes, Heather Woolery-Lloyd, MD, FAAD, Chief Medical Advisor for Nutrafol, discusses the issue of hair loss and thinning in men over 40 and a new solution for treatment ➡️ ow.ly/hBqv50Z7g7H #SkinMinute #Dermatology #Alopecia #Hair #HairLoss

INTEGUMENT-OLE and What’s Next for Pediatric AD: Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years. Watch here ➡️ ow.ly/qNh450Z5UEy

📢🚨PRACTICAL DERMATOLOGY MAY/JUNE ISSUE: The May/June 2026 issue of @PracticalDerm explores modern approaches to treating skin cancers—from gene expression profiling and immunotherapy to intralesional therapies and prevention. Read the full issue ➡️ ow.ly/i4e650Z6Qem #Dermatology #SkinCancer #CutaneousOncology #MedicalDermatology

🧵 New in @JAMADerm:Neoadjuvant #capecitabine showed promising activity in advanced cutaneous SCC of the head & neck. Potential bridge for patients awaiting surgery or unable to receive immunotherapy? Read more ➡️ ow.ly/a0PO50Z6msh #cSCC #Dermatology #SkinCancer

📢JUNE IS ACNE AWARENESS MONTH 🩺👉Acne is one of the most common dermatologic conditions worldwide—but its impact extends beyond the skin. This #AcneAwarenessMonth, we're highlighting the latest treatment advances, clinical research, and expert insights. Learn more at ow.ly/vThX50Z6n6y. #AcneAwarenessMonth #Dermatology #ClinicalResearch #HealthcareInnovation #MedicalEducation #SkinHealth

🎙️ 👨‍⚕️👨‍⚕️ SCIENCE OF SKIN PODCAST TALKS HIDRADENITIS SUPPURATIVA: In this episode of The Science of Skin Podcast, Practical Dermatology Editorial Board member and Science of Skin Summit Co-founder Edward (Ted) Lain, MD, MBA, is joined by Steven Daveluy, MD, FAAD, to discuss the complicated pathophysiology of hidradenitis suppurativa and the future of treatment capabilities for the disease ➡️ ow.ly/3Bbo50Z69OP #HidradenitisSuppurativa #SkinScience #SkinHealth #PracticalDermatologyPodcast #Dermatology #HSAwareness

📊🎤🩺GOING IN-DEPTH FOR PIGMENTARY DISORDERS: Pearl E. Grimes, MD, FAAD, previews the Pigmentary Disorders Exchange Symposium, which will be held June 6-7 at the Loews Chicago Hotel ➡️ ow.ly/GQAB50Z5UCX

One registration. Two industry-leading experiences. Unlimited opportunity to be part of the conversations shaping the future of aesthetic regenerative medicine. Genesis and the Tell-All Tribune bring together groundbreaking science, honest discussion, emerging trends, and real-world clinical application led by top physicians, scientists, and innovators. If you want more than surface-level education, this is where you need to be. Register early to secure the best rates before pricing increases! 📍 Miami, FL | August 21–22, 2026 🔗 ow.ly/TwEt50Z4LOZ

🧴📊🩺THE ROLE OF BPO IN LONG-TERM ACNE MANAGEMENT: In a recent virtual deskside given by Revance, speakers emphasized the importance of early #acne intervention to help reduce the risk of long-term physical and emotional scarring. Dermatologist Suneel Chilukuri, MD, participated in the discussion and highlighted growing consumer engagement with the #PanOxyl portfolio ➡️ ow.ly/Ppy350Z4Wbi #dermatology #acnemanagement #BPO #skinhealth #Skincare

🔎 ULTRASOUND FOR #PSORIASIS: New research suggests musculoskeletal ultrasound may detect subclinical inflammation in children with psoriasis before arthritis symptoms emerge. Pediatric patients showed more frequent synovitis and abnormal nail findings versus healthy controls📊 ➡️ ow.ly/Hp1u50Z4qbU #DermTwitter #Rheumatology #PediatricDermatology #Ultrasound

📢📊👉NEW DATA: Could botulinum toxin A have a larger role in acne management? A new systematic review of 436 patients found improvements in acne lesions, sebum production, and acne scarring outcomes lasting 3-6 months ➡️ ow.ly/6Cb350Z3SFF #DermTwitter #Acne #Aesthetics